CDE moved! Strategic cooperation with Beijing food and drug administration was also formed to build a procurement platform for reference preparations

Source: e drug manager January 17, 2018 CDE signed a strategic cooperation agreement with Beijing food and Drug Administration on December 27, 2017 to jointly promote the technical reform of drug review and approval This is the second strategic cooperation between the State Food and Drug Administration and the local food and drug administration According to the official website of the drug review center (CDE) of the State Food and drug administration, the office of the drug review center has been moved from No.1, Fuxing Road, Haidian District, Beijing to No.128, Jianguo Road, Chaoyang District, Beijing since January 22, 2018 Since January 22, 2018, the applicant's on-site submission of materials / official documents has been adjusted to No 128 Jianguo Road, Chaoyang District, Beijing The time and arrangement for receiving materials / official documents remain unchanged From January 19, 2018, the applicant should mail the materials / official documents to No.128 Jianguo Road, Chaoyang District, Beijing, 100022 Data receiver: Business Management Office of drug review center of State Food and drug administration; official document receiver: drug review center of State Food and drug administration CDE cooperated with Beijing food and drug administration to build a reference preparation procurement platform In order to better implement the opinions of the general office of the CPC Central Committee and the general office of the State Council on deepening the reform of the review and approval system and encouraging the innovation of pharmaceutical and medical devices, CDE signed a strategic cooperation agreement with Beijing food and Drug Administration on December 27, 2017 Sun Xianze, deputy director of the General Administration, attended the signing ceremony and delivered a speech Xu Jiaqi, director of CDE, and Cong Luoluo, director of Beijing food and drug administration, signed a strategic cooperation agreement on behalf of both sides LAN Fen, deputy director of the drug evaluation center, Zhou Siyuan, deputy director, Liang Hong, deputy director of Beijing food and drug administration, and Yao Shenglin, director of food and drug safety attended the signing ceremony Sun Xianze pointed out that the strategic cooperation agreement signed by the drug review center and Beijing food and drug administration can not only better serve the healthy development of the pharmaceutical industry in Beijing, but also provide a practical basis for the review and reform, which will make it easier to realize resource sharing and jointly improve the regulatory service capacity At the same time, the two sides can send each other to study and exercise on a temporary basis, which can greatly improve the ability level of the two sides' personnel The cooperation between the two sides is another new exploration for the construction of the evaluation system, promoting the complementary advantages of the state and the local, and jointly implementing the reform of the drug evaluation and approval system to encourage innovation According to the agreement, the two sides will conduct in-depth technical integration and extensive business cooperation around platform construction and capacity improvement The drug evaluation center will send young cadres to the food and drug administration system of Beijing for on-the-job training, set up a contact point for drug innovation services in Beijing, understand the work at the grass-roots level, and enhance the ability to solve practical problems Beijing food and Drug Administration will send drug review and inspection personnel to the drug review center to study on a temporary basis and participate in the technical review of innovative drugs after training, which is conducive to improving the ability and quality At the same time, the two sides have achieved resource sharing, complementary advantages, mutual benefits and win-win results in the construction of public service procurement platform for pharmaceutical reference preparations, drafting technical guidelines, and carrying out research projects The cooperation between the two sides is conducive to accelerating the reform of drug review and approval system and mechanism, serving the construction of capital science and technology innovation center, and is of great significance and value to accelerating the adjustment of drug industry structure and technological innovation in Beijing It is reported that this is the second strategic cooperation agreement signed by the provincial food and Drug Administration and the drug audit center On May 26 this year, CDE signed a strategic cooperation agreement with Shandong food and drug administration This time, CDE signed a supplementary agreement on strategic cooperation with Shandong food and drug administration CDE and Shandong food and Drug Administration signed a supplementary agreement on strategic cooperation on December 29, 2017 CDE and Shandong food and Drug Administration signed a supplementary agreement on strategic cooperation to jointly promote the construction of drug technology review capacity Later, director Xu Jiaqi and director Ma Yuenan jointly opened the "contact point of drug innovation and evaluation system reform" in Shandong Province on behalf of both sides